• Tuberculosis and Respiratory Diseases
• /
• v.86 no.2
• /
• pp.82-93
• /
• 2023

Tuberculosis (TB) is a significant public health concern. Globally, TB is among the top 10 and the leading cause of death due to a single infectious agent. Providing standard anti-TB therapy for at least 6 months is recommended as one of the crucial strategies to control the TB epidemic. However, the long duration of TB treatment raised the issue of non-adherence. Non-adherence to TB therapy could negatively affect clinical and public health outcomes. Thus, directly observed therapy (DOT) has been introduced as a standard strategy to improve anti-TB medication adherence. Nonetheless, the DOT approach has been criticized due to inconvenience, stigma, reduced economic productivity, and reduced quality of life, which ultimately could complicate adherence issues. Apart from that, its effectiveness in improving anti-TB adherence is debatable. Therefore, digital technology could be an essential tool to enhance the implementation of DOT. Incorporating the health belief model (HBM) into digital technology can further increase its effectiveness in changing behavior and improving medication adherence. This article aimed to review the latest evidence regarding TB medication non-adherence, its associated factors, DOT's efficacy and its alternatives, and the use of digital technology and HBM in improving medication adherence. This paper used the narrative review methodology to analyze related articles to address the study objectives. Conventional DOT has several disadvantages in TB management. Integrating HBM in digital technology development is potentially effective in improving medication adherence. Digital technology provides an opportunity to improve medication adherence to overcome various issues related to DOT implementation.

• Korean Journal of Digital Imaging in Medicine
• /
• v.3 no.1
• /
• pp.34-35
• /
• 1997

• Korean Journal of Digital Imaging in Medicine
• /
• v.8 no.1
• /
• pp.57-62
• /
• 2006

• Journal of the Korean Academy of Child and Adolescent Psychiatry
• /
• v.34 no.4
• /
• pp.192-203
• /
• 2023

Digital therapeutics based on software, such as artificial intelligence, virtual reality, games, and smartphone applications, are in the spotlight as new therapeutic alternatives in child and adolescent psychiatry. It draws attention to overcoming conventional therapeutics' limitations, such as toxicity, cost, and accessibility, and encourages patients to participate in the treatment attractively. The growth potential of the digital therapeutics market for psychiatric disorders in children and adolescents in Korea and abroad has been highlighted. Clinical studies and Food and Drug Administration approvals for digital therapeutics have increased, and cases approved by the Ministry of Food and Drug Safety have emerged in Korea. As seen above, digital transformation in child and adolescent psychiatry will change treatment paradigms significantly. Therefore, as this new field has just begun to emerge, it is necessary to verify the effectiveness and scope of the application of digital therapeutics and consider preparing a compensation system and institutional arrangements. Accordingly, this study analyzed the development trends and application status of digital therapeutics in children and adolescents and presented limitations and development directions from the perspective of application in healthcare. Further, the study is expected to identify the utility and limitations of digital therapeutics for children and adolescents and establish effective application measures.

• Sleep Medicine and Psychophysiology
• /
• v.28 no.1
• /
• pp.6-12
• /
• 2021

Insomnia is one of the most common sleep disorders experienced by modern people, and treatment is often not adequate due to various limitations. Digital therapeutics for insomnia are expected to play a revolutionary role in supplementing and satisfying unmet needs in real-world clinical treatment. Digital therapeutics for insomnia were developed based on cognitive-behavioral therapy for insomnia, which is the first standard treatment for insomnia. The effectiveness of digital therapeutics for insomnia developed by several companies has been proven through well-designed clinical research. Various approaches have been used for practical application of digital therapeutics for insomnia. Thus far, meaningful results have been drawn, but there are areas that need to be improved upon based on real-world evidence. Sleep researchers need to validate the safe and effective application of digital therapeutics for the treatment of insomnia.

• Journal of Veterinary Clinics
• /
• v.24 no.2
• /
• pp.218-224
• /
• 2007

Digital electrocardiogram (ECG) recorders are rapidly replacing to conventional paper ECG recorders. Digital ECG recorders have several advantages over conventional type ECG recorders, including better capability for data storage, better portability and better applicability in clinical settings. In this study, we presented 4 case studies related to cardiac rhythm disturbances, which were diagnosed and managed using a digital ECG recorder.

• Korean Journal of Digital Imaging in Medicine
• /
• v.3 no.1
• /
• pp.8-9
• /
• 1997

• Korean Journal of Digital Imaging in Medicine
• /
• v.3 no.1
• /
• pp.154-160
• /
• 1997

• Korean Journal of Digital Imaging in Medicine
• /
• v.3 no.1
• /
• pp.10-19
• /
• 1997

• Korean Journal of Digital Imaging in Medicine
• /
• v.3 no.1
• /
• pp.60-65
• /
• 1997